Add like
Add dislike
Add to saved papers

The effect of alternate occlusion on control of intermittent exotropia in children.

PURPOSE:: The aim is to investigate the effect of alternate occlusion on control of intermittent exotropia in children 3 to 8 years old.

METHODS:: The ability of 28 children to control of the deviation at far and near was evaluated based on 3-point and 6-point control scales. Stereopsis and fusion were assessed using the Titmus and Worth 4-dot tests, respectively. Two-hour alternate daily occlusion was prescribed for children with no dominancy. For children with a dominant eye, 2-h occlusion of the dominant eye for 5 days and the non-dominant eye for 2 days. All measurements were repeated at 3, 6, and 9 months after the treatment.

RESULTS:: For all children with a mean age of 4.7 ± 1.56 years, deviation control at far improved significantly after 3, 6, and 9 months of treatment using both control scales when compared with baseline ( p = 0.005 after 3 months and p = 0.008 after 6 and 9 months for the 3-point scale, and p < 0.001 after 3 and 6 months and p = 0.010 after 9 months for the 6-point scale). Control at near showed a significant improvement after 3, 6, and 9 months of treatment based on the 6-point scale ( p = 0.007 for 3 months, p = 0.004 for 6 months, and p = 0.014 for 9 months). Near stereopsis improved significantly after 9 months of treatment ( p = 0.043).

CONCLUSION:: Alternate occlusion is significantly effective on control of intermittent exotropia. As a result, it can be used as a useful method to postpone or even eliminate the need for surgery in intermittent exotropia.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app